Clinical Trial Update: A Study of DM005 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

DM005 is being studied in a Phase 1 trial for patients with advanced solid tumors, including non-small-cell lung cancer and head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• DM005 (DM005)

Snippet

Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd. | Conditions: Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck | Phase 1 | Status: RECRUITING